NI
GILD icon

Natural Investments’s Gilead Sciences GILD Stock Holding History

Natural Investments’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$929K Buy
7,354
+282
+4% +$37.2K 0.2% 102
2026
Q1 		$985K Sell
7,072
-30
-0.4% -$4.2K 0.24% 88
2025
Q4 		$871K Buy
7,102
+4,161
+141% +$506K 0.22% 99
2025
Q3 		$326K Buy
2,941
+76
+3% +$8.64K 0.08% 185
2025
Q2 		$317K Sell
2,865
-2,201
-43% -$234K 0.08% 196
2025
Q1 		$567K Buy
5,066
+79
+2% +$8.15K 0.16% 122
2024
Q4 		$460K Buy
+4,987
New +$449K 0.13% 145

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Natural Investments's GILD Position: Q2 2026 in Review

Natural Investments increased its Gilead Sciences (GILD) stake by 4% in Q2 2026, buying an estimated $37.2K and bringing the position to 7,354 shares worth $929K. The position accounts for 0.2% of the portfolio, ranked #102.

Natural Investments first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $985K in Q1 2026. 1,412 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Natural Investments held 7,354 shares of Gilead Sciences worth $929K as of Q2 2026.
  • Natural Investments bought 282 Gilead Sciences shares in Q2 2026, an estimated $37.2K.
  • Gilead Sciences made up 0.2% of Natural Investments's portfolio in Q2 2026, its #102 holding.
  • Natural Investments first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • Natural Investments's Gilead Sciences position peaked at $985K in Q1 2026.
  • 1,412 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Natural Investments's 13F filing for Q2 2026, filed 31 Jul 2026.